MS research breakthrough in Queensland
In a noteworthy stride towards alleviating the impact of multiple sclerosis (MS), a groundbreaking accomplishment has been achieved by Queensland scientists.
MS Queensland is immensely proud to share that QIMR Berghofer, in its unwavering pursuit of eradicating this debilitating disease, has developed an innovative vaccine candidate that holds promise in providing enduring and potent protection against the Epstein–Barr virus (EBV), a widely suspected contributing factor linked to MS.
This remarkable achievement is a testament to years of meticulous research by QIMR Berghofer investigating the role of EBV in various diseases and cancers.
The journey has led to this pivotal juncture where the development of the vaccine has advanced significantly, marking a moment of pride for all involved.
Dr Vijayendra Dasari, the lead author of this groundbreaking research, expressed his gratification at witnessing the culmination of extensive efforts.
“QIMR Berghofer’s longstanding commitment to exploring the implications of EBV in disease and cancer has borne fruit. It is truly gratifying to witness the convergence of these research endeavours as we propel this vaccine towards its crucial developmental stages,” Dr Dasari remarked.
Professor Rajiv Khanna is leading the charge in this pioneering initiative whose leadership has guided the creation of this vaccine.
The study highlights the potential of the vaccine to furnish effective, long-lasting protection against EBV.
The significance of this achievement is underscored by the fact that individuals contracting the EBV virus during adolescence or early adulthood are at risk of developing infectious mononucleosis or glandular fever, conditions that greatly heighten the likelihood of MS and certain cancers. The full research paper is available here.
Janine Watson, a celebrated Brisbane Paralympian and MS Queensland Ambassador diagnosed with MS at age 26 resonates deeply with the importance of this breakthrough.
She voices her optimism in the wake of QIMR’s achievement, envisioning a future where younger generations might be spared the burden of MS.
“Many young individuals are receiving the devastating diagnosis of this ailment. The prospect of having a preventive vaccine is truly uplifting,” Janine shares. “MS is progressive, and with time, my abilities have dwindled. Being able to witness this stride is incredibly heartening.”
MS Queensland stands united with the dedicated researchers and the resilient individuals living with MS, collectively hopeful that this scientific breakthrough heralds a brighter future for Queenslanders.
“MS Australia is delighted to have supported the MS EBV Research Program at QIMR Berghofer Medical Research Institute in its infancy, and congratulates them on this significant achievement.” - MS Australia.
Last year, thanks to our wonderful community of supporters, MS Queensland contributed over $867,000 to MS research projects to ensure one day we can live in a world without MS.
If you would like to support research like this, please consider donating today.
